Nuclear Medicine and Biology
Volume 34, Issue 3 , Pages 267-272 , April 2007

Biodistribution and PET imaging of [18F]-fluoroadenosine derivatives

Received 22 November 2006 ,Accepted 25 December 2006.

References 

  1. Right JA, Taylor NF. Fluorocarbohydrates. Part XVIII. 9-(3-Deoxy-3-fluoro-(-d-xylofuranosyl)adenine and 9-(3-deoxy-3-fluoro-(-d-arabinofuranosyl)adenine. Carbohydr Res. 1968;6:347–354
  2. Right JA, Taylor NF, Fox JJ. Synthesis of 2-deoxy-2-fluoro-d-arabinose and 9-(2-deoxy-2-fluoro-α- and β-d-arabinofuranosyl)adenine. J Org Chem. 1969;34:2632–2636
  3. Ikehara M, Maruyama T, Miki H. Studies of nucleosides and nucleotides. LXXIV. Purine cyclonucleoside-34; a new method for the synthesis of 2′-substituted 2′-deoxyadenosine. Tetrahedron. 1978;34:1133–1138
  4. Pankiewicz KW, Krzeminski J, Ciszeski LA, Ren WY, Watanabe KA. A synthesis of 9-(2-deoxy-2-fluoro-β-d-arabinofuranosyl)adenine and hypoxanthine. J Org Chem. 1992;57:553–559
  5. Montgomery JA, Shortnacy-Fowler TS, Clayton SD, Riordan JM, Secrist JA. Synthesis and biological activity 2′-fluoro-2-halo-derivatives of 9-β-d-arabinofuranosyladenine. J Med Chem. 1992;35:397–401
  6. Carson DA, Wasson DB, Esparza LM, Carrera CJ, Kipps T, Cottam HB. Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2′-arabino-fluoro-2′-deoxyadenosine. Proc Natl Acad Sci U S A. 1992;89:2970–2974
  7. Takahashi T, Kanazawa J, Akinaga S, Tamoaki T, Okabe M. Antitumor activity of 2-chloro-9-(2-deoxy-2-fluoro-β-d-arabinofuranosyl)adenine, a novel deoxyadenosine analogue, against human colon tumor xenographs by oral administration. Cancer Chemother Pharmacol. 1999;43:233–240
  8. Kim CG, Yang DJ, Kim EE, Cherif A, Kuang L, Li C, et al. Assessment of tumor cell proliferation using [18F]-fluorodeoxyadenosine and [18F]-fluoroethyluracil. J Pharm Chem. 1996;85:339–344
  9. Mikhailopulo IA, Poopeiko NE, Prikota TI, Sivets GG, Kvasyuk EI, Balzirini J, et al. Synthesis and antiviral and cytostatic properties of 3′-deoxy-3′-fluoro- and 2′-azido-3′-fluoro-2′,3′-dideoxy-d-ribofuranosides of natural heterocyclic bases. J Med Chem. 1991;34:2195–2202
  10. Van Aerschot A, Herdewijin P, Jansen G, Cools M, De clerq E. Synthesis and antiviral activity evaluation of 3′-fluoro-3′-deoxyribonucleosides: broad-spectrum activity of 3′-fluoro-3′-deoxyadenosine. Antiviral Res. 1989;12:133–150
  11. Smee DF, Morris JL, Barnard DL, Van Aerschot A. Selective inhibition of arthropod-borne and arenaviruses in vitro by 3′-fluoro-3′-deoxyadenosine. Antiviral Res. 1992;18:151–162
  12. Robins MJ, Fouron Y, Mengel R. Nucleic acid related compounds: 11. Adenosine 2′,3′-ribo-epoxide. Synthesis, intramolecular degradation, and transformation into 3′-substituted xylofuranosyl nucleosides and the lyxo-epoxide. J Org Chem. 1974;39:1564–1570
  13. Lewandowska E, Neschadimenko V, Wnuk SF, Robins MJ. Efficient removal of sugar O-tosyl groups and heterocycle halogens from purine nucleosides with sodium naphthalenide. Tetrahedron. 1997;53:6295–6302
  14. Lauer T, Loncar R, Deussen A. Tracer adenosine: a novel myocardial flow marker. J Nucl Med. 2003;44:641–648
  15. Mathews WB, Nakamoto Y, Ravert HT, Scheffel U, Rauseo PA, Traughber B, et al. 11C-5′-Adenosine monophosphate (11C-AMP): a new radioligand for positron emission tomographic imaging of cancer. J Nucl Med. 2002;43:362P
  16. Alauddin MM, Conti PS, Fissekis JD. Synthesis of [18F]-labeled 2′-deoxy-2′-fluoro-1-β-d-arabinofuranosyluracil ([18F]FMAU). J Labelled Comp Radiopharm. 2002;45:583–590
  17. Alauddin MM, Conti PS, Fissekis JD. A general synthesis of [18F]-labeled 2′-deoxy-2′-fluoro-1-β-d-arabinofuranosyluracil nucleosides. J Labelled Comp Radiopharm. 2003;46:285–289
  18. Alauddin MM, Conti PS, Fissekis JD. Synthesis of [18F]-labeled adenosine analogues as potential PET imaging agents. J Labelled Comp Radiopharm. 2003;46:805–814

PII: S0969-8051(07)00005-4

doi: 10.1016/j.nucmedbio.2006.12.009

Nuclear Medicine and Biology
Volume 34, Issue 3 , Pages 267-272 , April 2007

Article Tools

* Image Usage & Resolution